Heart failure therapeutics on the basis of a biased ligand of the angiotensin-2 type 1 receptor. Rationale and design of the BLAST-AHF study (Biased Ligand of the Angiotensin Receptor Study in Acute Heart Failure).
暂无分享,去创建一个
P. Ponikowski | G. Filippatos | G. Felker | M. Metra | J. Butler | A. Voors | D. Soergel | J. Ezekowitz | G. Cotter | Jonathan D. Violin | J. Teerlink | B. Davison | Peter S. Pang | Phillip D. Levy | Sean P Collins